InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,566.42
(
-0.01%
)
US TECH 100
19,862.80
(
0.08%
)
Dow Jones
39,293.14
(
-0.21%
)
Brent Oil
85.74
(
-0.89%
)
Bitcoin
55,780.28
(
-0.12%
)
Post# of 252513
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: DewDiligence post# 47936

Sunday, 06/03/2007 8:23:34 AM

Sunday, June 03, 2007 8:23:34 AM

Post# of 252513
Jazz Pharma acquired Orphan medical who already had Xyrem on the (US) market at the time. If my recollection is correct there was a slight premium when they were acquired. Orphan Medical was studying it in a few larger indications I believe Fibromyalgia was one. When they were acquired I stopped following what happened to that trial.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up